Glaxosmithkline Pharma standalone net profit declines 5.10% in the June 2015 quarter

Sales decline 5.06% to Rs 621.85 crore

Net profit of Glaxosmithkline Pharma declined 5.10% to Rs 93.28 crore in the quarter ended June 2015 as against Rs 98.29 crore during the previous quarter ended June 2014. Sales declined 5.06% to Rs 621.85 crore in the quarter ended June 2015 as against Rs 654.96 crore during the previous quarter ended June 2014. ParticularsQuarter EndedJun. 2015Jun. 2014% Var.Sales621.85654.96 -5 OPM %17.6917.44 -PBDT149.89154.05 -3 PBT144.97149.04 -3 NP93.2898.29 -5

Powered by Capital Market - Live News